On Friday, Sana Biotechnology Inc (NASDAQ: SANA) opened lower -1.55% from the last session, before settling in for the closing price of $7.73. Price fluctuations for SANA have ranged from $2.74 to $12.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 18.26% at the time writing. With a float of $122.54 million, this company’s outstanding shares have now reached $197.86 million.
Let’s determine the extent of company efficiency that accounts for 328 employees.
Sana Biotechnology Inc (SANA) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Sana Biotechnology Inc is 44.41%, while institutional ownership is 40.59%. The most recent insider transaction that took place on Mar 08 ’24, was worth 236,300. In this transaction Director of this company sold 25,000 shares at a rate of $9.45, taking the stock ownership to the 149,250 shares. Before that another transaction happened on Feb 08 ’24, when Company’s Director bought 1,818,181 for $5.50, making the entire transaction worth $9,999,996. This insider now owns 12,446,022 shares in total.
Sana Biotechnology Inc (SANA) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 268.80 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.26% per share during the next fiscal year.
Sana Biotechnology Inc (NASDAQ: SANA) Trading Performance Indicators
Check out the current performance indicators for Sana Biotechnology Inc (SANA). In the past quarter, the stock posted a quick ratio of 3.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.36 in one year’s time.
Technical Analysis of Sana Biotechnology Inc (SANA)
Looking closely at Sana Biotechnology Inc (NASDAQ: SANA), its last 5-days average volume was 1.93 million, which is a drop from its year-to-date volume of 3.1 million. As of the previous 9 days, the stock’s Stochastic %D was 9.84%. Additionally, its Average True Range was 0.65.
During the past 100 days, Sana Biotechnology Inc’s (SANA) raw stochastic average was set at 49.19%, which indicates a significant increase from 14.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.77% in the past 14 days, which was lower than the 105.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.85, while its 200-day Moving Average is $5.74. However, in the short run, Sana Biotechnology Inc’s stock first resistance to watch stands at $7.88. Second resistance stands at $8.16. The third major resistance level sits at $8.47. If the price goes on to break the first support level at $7.29, it is likely to go to the next support level at $6.98. Now, if the price goes above the second support level, the third support stands at $6.70.
Sana Biotechnology Inc (NASDAQ: SANA) Key Stats
There are currently 220,448K shares outstanding in the company with a market cap of 1.68 billion. Presently, the company’s annual sales total 0 K according to its annual income of -283,260 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -88,120 K.
